People in England and Wales will soon have access to a long-lasting HIV prevention jab for the first time. The National ...

The recent approval of lenacapavir could change the way that clinicians approach both treating and preventing HIV in those at risk, as long as the treatment can get into their hands. Gordon Crofoot, ...

This past Winter Session, 12 University students traveled to Israel as part of BIOL 1980: “HIV/AIDS in Diverse Settings: Focus on Israel.” The course examines HIV/AIDS in the context of Israel’s ...

In a memo, the state health department explained the new restrictions are the result of an “unprecedented increase in program ...

With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market and growth in its three therapeutic areas driving momentum beyond HIV, the ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain demographics and a lack of representation in media, the Gay and Lesbian Alliance ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...